Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Charcot-Marie-Tooth disease associated with periaxin mutations (CMT4F): Clinical, electrophysiological and genetic analysis of 24 patients.]
Toxicological aspects of injectable gold-hyaluronan combination as a treatment for neuroinflammation.
Glutamate, Glutamate Receptors, and Downstream Signaling Pathways.
Ocular side effects of drugs used in the treatment of multiple sclerosis.
Interferon-beta or azathioprine as add-on therapies in patients with active multiple sclerosis.
JC virus seroprevalence and seroconversion in multiple sclerosis cohort: A Middle-Eastern study.
Masquerading optic neuritis.
Agent based modeling of the effects of potential treatments over the blood-brain barrier in multiple sclerosis.
An Individualized Yoga Programme for Multiple Sclerosis: A Case Study.
Neuroprotective Effects of Transplanted Mesenchymal Stromal Cells-derived Human Umbilical Cord Blood Neural Progenitor Cells in EAE.
Detection of differential protein expression in cerebrospinal fluid of patients with multiple sclerosis through two-dimensional differential in gel electrophoresis.
Exercise barriers and preferences among women and men with multiple sclerosis.
Iron accumulation in multiple sclerosis: an early pathogenic event.
Multiple sclerosis update.
Both positive and negative effects on immune responses by expression of a second class II MHC molecule.
Heterogeneous induction of microglia M2a phenotype by central administration of interleukin-4.
'The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level - YES'.
A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing-remitting multiple sclerosis.
Multiple sclerosis patients' experiences in relation to the impact of the kinect virtual home-exercise programme: a qualitative study.
A rare case of Balo concentric sclerosis showing unusual clinical improvement and response with oral prednisolone.
Magnetic resonance monitoring of lesion evolution in multiple sclerosis.
Combined therapy with methylprednisolone and ulinastatin in experimental autoimmune encephalomyelitis.
Anti Mycobacterium avium subsp. paratuberculosis heat shock protein 70 antibodies in the sera of Sardinian patients with multiple sclerosis.
New insights in the pathogenesis of multiple sclerosis-role of acrolein in neuronal and myelin damage.
Clinical experience with THC:CBD oromucosal spray in patients with multiple sclerosis-related spasticity.
Pages
« first
‹ previous
…
472
473
474
475
476
477
478
479
480
…
next ›
last »